{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:01:56Z","timestamp":1789372916588,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ejps.2013.02.005","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T22:01:55Z","timestamp":1361570515000},"page":"81-89","source":"Crossref","is-referenced-by-count":21,"title":["pH-gradient PAMPA-based in vitro model assay for drug-induced phospholipidosis in early stage of drug discovery"],"prefix":"10.1016","volume":"49","author":[{"given":"Gy\u00f6rgy T.","family":"Balogh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1rp\u00e1d","family":"K\u00f6ncz\u00f6l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2013.02.005_b0005","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett."},{"issue":"Suppl","key":"10.1016\/j.ejps.2013.02.005_b0010","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/0006-2952(91)90405-T","article-title":"Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture","volume":"42","author":"Antonini","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2013.02.005_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2013.02.005_b0020","first-page":"61","volume":"57","author":"Avdeef","year":"2003","journal-title":"Chimia"},{"key":"10.1016\/j.ejps.2013.02.005_b0025","doi-asserted-by":"crossref","unstructured":"Avdeef, A., 2003b. Absorption and Drug Development Solubility, Permeability and Charge State. pION, Inc. John Wiley & Sons, pp. 116\u2013152.","DOI":"10.1002\/047145026X.ch7"},{"key":"10.1016\/j.ejps.2013.02.005_b0030","doi-asserted-by":"crossref","unstructured":"Avdeef, A., 2003c. Absorption and Drug Development Solubility, Permeability and Charge State. pION, Inc. John Wiley & Sons.","DOI":"10.1002\/047145026X"},{"key":"10.1016\/j.ejps.2013.02.005_b0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejps.2007.09.009","article-title":"Absorption-excipient-pH classification gradient maps: sparingly soluble drugs and the pH partition hypothesis","volume":"33","author":"Avdeef","year":"2008","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.02.005_b0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/00498258809041660","article-title":"Metabolism and kinetics of amlodipine in man","volume":"18","author":"Beresford","year":"1988","journal-title":"Xenobiotica Fate Foreign Compounds Biol. Syst."},{"key":"10.1016\/j.ejps.2013.02.005_b0045","doi-asserted-by":"crossref","unstructured":"Berridge, B.R., Chatman, L.A., Odin, M., Schultze, A.E., Losco, P.E., Meehan, J.T., Peters, T., Vonderfecht, S.L., Society of Toxicologic Pathology, S., Regulatory Policy Committee Working, G., 2007. Phospholipidosis in nonclinical toxicity studies. Tox. Path. 35, 325.","DOI":"10.1080\/01926230701196414"},{"key":"10.1016\/j.ejps.2013.02.005_b0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1024778329320","article-title":"A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development","volume":"19","author":"Casartelli","year":"2003","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejps.2013.02.005_b0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2013.02.005_b0060","unstructured":"Fischer, H., Kansy, M., Potthast, M., Csato, M., 1998. Rational Approaches to Drug Design. In: Proceedings of the 13th European Symposium on Quantitative Structure\u2013Activity Relationships. Prous Science, Barcelona."},{"key":"10.1016\/j.ejps.2013.02.005_b0065","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0006-2952(01)00823-1","article-title":"Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes(1)","volume":"62","author":"Gum","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2013.02.005_b0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejps.2013.02.005_b0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/tx9003825","article-title":"Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds","volume":"23","author":"Hanumegowda","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejps.2013.02.005_b0080","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3109\/00498259009046842","article-title":"Human accumulation potential of xenobiotics: potential of catamphiphilic drugs to promote their accumulation via inducing lipidosis or mucopolysaccharidosis","volume":"20","author":"Hein","year":"1990","journal-title":"Xenobiotica Fate Foreign Compounds Biol. Syst."},{"key":"10.1016\/j.ejps.2013.02.005_b0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpba.2011.11.033","article-title":"Chromatography approaches for early screening of the phospholipidosis-inducing potential of pharmaceuticals","volume":"61","author":"Jiang","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2013.02.005_b0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0005-2760(89)90078-7","article-title":"Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis","volume":"1004","author":"Joshi","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2013.02.005_b0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0014-4800(81)90010-1","article-title":"Role of drug metabolism in protection against chlorphentermine-induced pulmonary phospholipidosis in adult rat","volume":"35","author":"Kacew","year":"1981","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ejps.2013.02.005_b0100","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3109\/00498258809042231","article-title":"A comparative in vitro metabolic study of methaphenilene and pyribenzamine","volume":"18","author":"Kammerer","year":"1988","journal-title":"Xenobiotica Fate Foreign Compounds Biol. Syst."},{"key":"10.1016\/j.ejps.2013.02.005_b0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ddtec.2004.11.013","article-title":"Advances in screenincg formembrane permeability: high-resolution PAMPA for medicinal chemists","volume":"1","author":"Kansy","year":"2004","journal-title":"Drug Discovery Today Technol."},{"key":"10.1016\/j.ejps.2013.02.005_b0110","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2013.02.005_b0115","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3109\/00498259209056688","article-title":"Metabolism of methapyrilene by Fischer-344 rat and B6C3F1 mouse hepatocytes","volume":"22","author":"Kelly","year":"1992","journal-title":"Xenobiotica Fate Foreign Compounds Biol. Syst."},{"key":"10.1016\/j.ejps.2013.02.005_b0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF02976712","article-title":"Cytochrome P450 2C8 and CYP3A4\/5 are involved in chloroquine metabolism in human liver microsomes","volume":"26","author":"Kim","year":"2003","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.ejps.2013.02.005_b0125","first-page":"327","article-title":"Cationic amphiphilic drugs and phospholipid storage disorder","volume":"42","author":"Kodavanti","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2013.02.005_b0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1165\/ajrcmb\/4.4.369","article-title":"Amiodarone- and desethylamiodarone-induced pulmonary phospholipidosis, inhibition of phospholipases in vivo, and alteration of [14C]amiodarone uptake by perfused lung","volume":"4","author":"Kodavanti","year":"1991","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejps.2013.02.005_b0135","first-page":"80","article-title":"Phenacetin deacetylase activity in human liver microsomes: distribution, kinetics, and chemical inhibition and stimulation","volume":"294","author":"Kudo","year":"2000","journal-title":"J. Pharmacol Exp Therap."},{"key":"10.1016\/j.ejps.2013.02.005_b0140","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(78)90435-5","article-title":"Lipidosis induced by amphiphilic cationic drugs","volume":"27","author":"Lullmann","year":"1978","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2013.02.005_b0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13318-011-0065-6","article-title":"Effects of sertraline on the pharmacokinetics of bupropion and its major metabolite, hydroxybupropion, in mice","volume":"37","author":"Molnari","year":"2012","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2013.02.005_b0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0176-z","article-title":"Validation of an in vitro screen for phospholipidosis using a high-content biology platform","volume":"22","author":"Morelli","year":"2006","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejps.2013.02.005_b0155","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/BF02534010","article-title":"Characteristics of phospholipids in human lung carcinoma","volume":"15","author":"Nakamura","year":"1980","journal-title":"Lipids"},{"key":"10.1016\/j.ejps.2013.02.005_b0160","first-page":"454","article-title":"Chloroquine (SN-7618) pathologic changes observed in rats which for 2 years had been fed various proportions","volume":"45","author":"Nelson","year":"1948","journal-title":"Arch. Pathol."},{"key":"10.1016\/j.ejps.2013.02.005_b0165","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/ci6004542","article-title":"Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential","volume":"47","author":"Pelletier","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejps.2013.02.005_b0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/tx100262c","article-title":"Cellular responses associated with dibucaine-induced phospholipidosis","volume":"24","author":"Peropadre","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejps.2013.02.005_b0175","first-page":"347","article-title":"Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines","volume":"55","author":"Ploemen","year":"2004","journal-title":"Exp Tox. Path: Off. J. Gesellschaft fur Toxikologische Pathologie"},{"key":"10.1016\/j.ejps.2013.02.005_b0180","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.2174\/092986709788803213","article-title":"Medicinal chemistry strategies to minimize phospholipidosis","volume":"16","author":"Ratcliffe","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2013.02.005_b0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0041-008X(89)90054-9","article-title":"A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs","volume":"97","author":"Reasor","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2013.02.005_b0190","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: are there functional consequences?","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejps.2013.02.005_b0195","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/0006-2952(90)90614-Q","article-title":"Formation of cytotoxic metabolites from phenytoin, imipramine, desipramine, amitriptyline and mianserin by mouse and human hepatic microsomes","volume":"39","author":"Riley","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2013.02.005_b0200","first-page":"117","article-title":"QSAR and multivariate data analysis of the interaction of amphiphilic drugs with phospholipids","volume":"291","author":"Seydel","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.ejps.2013.02.005_b0205","first-page":"361","article-title":"The gastric secretion of drugs: a pH partition hypothesis","volume":"119","author":"Shore","year":"1957","journal-title":"J. Pharmacol Exp. Ther."},{"key":"10.1016\/j.ejps.2013.02.005_b0210","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejps.2012.01.011","article-title":"Skin-PAMPA: a new method for fast prediction of skin penetration","volume":"45","author":"Sinko","year":"2012","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.02.005_b0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/108705710100600309","article-title":"High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeation assay","volume":"6","author":"Sugano","year":"2001","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ejps.2013.02.005_b0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-5173(01)00845-6","article-title":"Optimized conditions of bio-mimetic artificial membrane permeation assay","volume":"228","author":"Sugano","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2013.02.005_b0225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2131\/jts.31.315","article-title":"Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential","volume":"31","author":"Tomizawa","year":"2006","journal-title":"J. Tox. Sci."},{"key":"10.1016\/j.ejps.2013.02.005_b0230","first-page":"542","article-title":"Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog","volume":"17","author":"Tremaine","year":"1989","journal-title":"Drug Metab. Dispos: Biol Fate Chem."},{"key":"10.1016\/j.ejps.2013.02.005_b0235","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11095-010-0280-x","article-title":"Physicochemical selectivity of the BBB microenvironment governing passive diffusion\u2013matching with a porcine brain lipid extract artificial membrane permeability model","volume":"28","author":"Tsinman","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2013.02.005_b0240","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/15376519109044560","article-title":"An in vitro fluorescence assay for the detection of drug-induced cytoplasmic lamellar bodies","volume":"1","author":"Ulrich","year":"1991","journal-title":"Toxicol. Methods"},{"key":"10.1016\/j.ejps.2013.02.005_b0245","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1007\/s11095-010-0150-6","article-title":"In situ artificial membrane permeation assay under hydrodynamic control: permeability-pH profiles of warfarin and verapamil","volume":"27","author":"Velicky","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2013.02.005_b0250","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1021\/jm7013953","article-title":"Assessment of drug\u2013lipid complex formation by a high-throughput Langmuir-balance and correlation to phospholipidosis","volume":"51","author":"Vitovic","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2013.02.005_b0255","first-page":"49","article-title":"The twenty-seventh scientific meeting of the japanese society of electron microscopy","volume":"20","author":"Watanabe","year":"1971","journal-title":"J. Electron Microsc."},{"key":"10.1016\/j.ejps.2013.02.005_b0260","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/jm001020e","article-title":"High-throughput permeability pH profile and high-throughput alkane\/water log P with artificial membranes","volume":"44","author":"Wohnsland","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2013.02.005_b0265","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jn\/95.3.381","article-title":"Lipid composition of heart, kidney and lung in guinea pigs made anemic by dietary cholesterol","volume":"95","author":"Yamanaka","year":"1968","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejps.2013.02.005_b0270","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1359-6446(03)02873-3","article-title":"In vitro trans-monolayer permeability calculations: often forgotten assumptions","volume":"8","author":"Youdim","year":"2003","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.ejps.2013.02.005_b0275","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1021\/ac200683k","article-title":"Predicting phospholipidosis: a fluorescence noncell based in vitro assay for the determination of drug\u2013phospholipid complex formation in early drug discovery","volume":"83","author":"Zhou","year":"2011","journal-title":"Anal. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871300064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871300064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T01:45:17Z","timestamp":1562723117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809871300064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S092809871300064X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2013.02.005","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}